The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status
Background/Aims: Ovarian cancer is often diagnosed at later stages with poor prognosis. Recent studies have associated the expression of deubiquitylase USP7 with the survival of ovarian cancers. Being a cysteine protease, USP7 could become a target for pharmacological intervention. Therefore, in thi...
Main Authors: | Mengying Wang, Yayun Zhang, Taishu Wang, Jinrui Zhang, Zhu Zhou, Yan Sun, Shanshan Wang, Yulin Shi, Xuelin Luan, Yingqiu Zhang, Yifei Wang, Yang Wang, Zhongwen Zou, Lan Kang, Han Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-10-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/484062 |
Similar Items
-
USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
by: Jae Eun Lee, et al.
Published: (2020-05-01) -
Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10
by: Rui Yang, et al.
Published: (2022-03-01) -
USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2
by: Jinhong Cho, et al.
Published: (2020-05-01) -
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
by: Keqiang Zhang, et al.
Published: (2023-11-01) -
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
by: Si-Min Qi, et al.
Published: (2020-04-01)